- Home
- AVD vs LUCD Comparison
AVD vs LUCD Comparison
Compare AVD & LUCD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AVD | LUCD |
|---|---|---|
| Founded | 1969 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Agricultural Chemicals | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 114.2M | 132.4M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | AVD | LUCD |
|---|---|---|
| Price | $3.82 | $1.08 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 4 |
| Target Price | ★ $12.00 | $3.94 |
| AVG Volume (30 Days) | 208.3K | ★ 710.1K |
| Earning Date | 11-10-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $530,073,000.00 | $4,399,000.00 |
| Revenue This Year | N/A | $11.18 |
| Revenue Next Year | $3.54 | $147.43 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 5.01 |
| 52 Week Low | $3.28 | $0.78 |
| 52 Week High | $6.33 | $1.80 |
Technical Indicators
Market Signals| Indicator | AVD | LUCD |
|---|---|---|
| Relative Strength Index (RSI) | 33.73 | 47.51 |
| Support Level | $3.82 | $1.09 |
| Resistance Level | $4.04 | $1.15 |
| Average True Range (ATR) | 0.16 | 0.04 |
| MACD | 0.00 | -0.01 |
| Stochastic Oscillator | 3.62 | 33.33 |
Price Performance
Historical ComparisonAbout AVD American Vanguard Corporation ($0.10 Par Value)
American Vanguard Corp is a United States-based diversified specialty and agricultural products company. It manufactures and formulates chemicals for crops, turf and ornamental plants, and human and animal health protection. These chemicals include insecticides, fungicides, herbicides, molluscicides, growth regulators, and soil fumigants, which are marketed in liquid, powder, and granular forms.
About LUCD Lucid Diagnostics Inc.
Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically lethal esophageal adenocarcinoma. Its products include EsoCheck and EsoGuard.